269 related articles for article (PubMed ID: 29509636)
1. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
[TBL] [Abstract][Full Text] [Related]
3. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
[TBL] [Abstract][Full Text] [Related]
5. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
[TBL] [Abstract][Full Text] [Related]
7. STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy.
Mougey EB; Nguyen V; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Borrell B; Román E; González-Lois C; Chao M; Al-Atrash H; Franciosi JP
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2046-2053.e2. PubMed ID: 32798708
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis: Predictive Factors and Long-Term Step-Down Efficacy.
Gutiérrez-Junquera C; Fernández-Fernández S; Domínguez-Ortega G; Vila Miravet V; García-Puig R; La Orden-Izquierdo E; Peña Quintana L; Barrio Torres J; Medina Benítez E; Leis R; García-Romero R; Fernández de Valderrama A; Vecino López R; Donado Palencia P;
J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):191-198. PubMed ID: 36416845
[TBL] [Abstract][Full Text] [Related]
9. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
[TBL] [Abstract][Full Text] [Related]
11. Conservative long-term treatment of children with eosinophilic esophagitis.
Levine J; Lai J; Edelman M; Schuval SJ
Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
[TBL] [Abstract][Full Text] [Related]
12. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
[TBL] [Abstract][Full Text] [Related]
13. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
Dellon ES; Speck O; Woodward K; Gebhart JH; Madanick RD; Levinson S; Fritchie KJ; Woosley JT; Shaheen NJ
Am J Gastroenterol; 2013 Dec; 108(12):1854-60. PubMed ID: 24145677
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.
Molina-Infante J; Rodriguez-Sanchez J; Martinek J; van Rhijn BD; Krajciova J; Rivas MD; Barrio J; Moawad FJ; Martinez-Alcalá C; Bredenoord AJ; Zamorano J; Dellon ES
Am J Gastroenterol; 2015 Nov; 110(11):1567-75. PubMed ID: 26416193
[TBL] [Abstract][Full Text] [Related]
15. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
16. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
Dohil R; Newbury RO; Aceves S
Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
[TBL] [Abstract][Full Text] [Related]
17. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Molina-Infante J; Katzka DA; Gisbert JP
Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
Frandsen LT; Westmark S; Melgaard D; Krarup AL
United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
[TBL] [Abstract][Full Text] [Related]
19. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis.
Oliva S; Rossetti D; Papoff P; Tiberti A; Mallardo S; Volpe D; Ruggiero C; Russo G; Vezzoli D; Isoldi S; Cucchiara S
Dig Dis Sci; 2019 Jun; 64(6):1571-1578. PubMed ID: 30659470
[TBL] [Abstract][Full Text] [Related]
20. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required.
Lipka S; Muhammad A; Champeaux A; Richter JE
Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
